Entero Healthcare Solutions Limited has submitted a regulatory disclosure to BSE Limited and National Stock Exchange of India Limited regarding scheduled investor meetings. The disclosure is made pursuant to Regulation 30(6) read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Company officials will attend an investor conference with the following details:
- Date: September 2, 2026
- Time: 3:00 PM onwards
- Interaction Type: 1x1 / Group Meeting
- Organized by: Elara Capital
- Mode: Physical
- Location: Mumbai
The company explicitly states that discussions during these interactions will be based solely on publicly available information, and no unpublished price-sensitive information (UPSI) is intended to be discussed.
The disclosure includes a note that changes to the schedule may occur due to exigencies on the part of participants or the company.
The letter was digitally signed by Sanu Vishal Kapoor, Vice President- Group General Counsel, Company Secretary & Compliance Officer of Entero Healthcare Solutions Limited, on August 24, 2026 at 19:21:57 +05:30.